Real World Use of Lenacapavir, as an add-on to an Optimized Background Regimen in France

RecruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

March 3, 2025

Primary Completion Date

August 31, 2025

Study Completion Date

December 31, 2025

Conditions
HIV I Infection
Interventions
DRUG

Lenacapavir Injection

"Patients will be included if they initiated LEN from 20 June 2023 to 30 June 2024.~All collected data are routinely reported by clinicians in medical records. All clinical decisions All collected data are routinely reported by clinicians in medical records, and will be collected using a dedicated electronic case report form (eCRF) created on this purpose, to ensure confidentiality of data."

Trial Locations (1)

75013

RECRUITING

Hôpital Pitié-Salpêtrière, Paris

All Listed Sponsors
lead

Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida

OTHER